Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.
Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...
Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new stu ...
A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.
Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...
Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...
Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...
Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.
A randomized study has produced some hopeful news for colorectal cancer survivors with an unlikely suspect: the commonly used ...
Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.